UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6265) 6265
Book Chapter (26) 26
Newspaper Article (6) 6
Dissertation (3) 3
Magazine Article (2) 2
Book / eBook (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (5999) 5999
humans (5978) 5978
science & technology (4997) 4997
life sciences & biomedicine (4800) 4800
endometrial neoplasms - metabolism (3171) 3171
endometrial neoplasms - pathology (2926) 2926
endometrial cancer (2593) 2593
oncology (2577) 2577
middle aged (2502) 2502
aged (1883) 1883
adult (1763) 1763
endometrial neoplasms - genetics (1702) 1702
cancer (1496) 1496
immunohistochemistry (1479) 1479
obstetrics & gynecology (1207) 1207
cell line, tumor (1106) 1106
prognosis (984) 984
pathology (872) 872
animals (847) 847
endometrium (828) 828
aged, 80 and over (821) 821
endometrium - metabolism (777) 777
gene expression regulation, neoplastic (691) 691
endometrial carcinoma (685) 685
neoplasm staging (684) 684
endometrial neoplasms - drug therapy (649) 649
adenocarcinoma - metabolism (643) 643
biomarkers, tumor - metabolism (610) 610
gene expression (609) 609
adenocarcinoma - pathology (585) 585
risk factors (585) 585
research (568) 568
tumors (548) 548
endometrium - pathology (536) 536
tumor cells, cultured (530) 530
analysis (528) 528
cell biology (522) 522
carcinoma, endometrioid - metabolism (488) 488
mice (485) 485
apoptosis (471) 471
carcinoma, endometrioid - pathology (457) 457
endocrinology & metabolism (454) 454
endometrial neoplasms - enzymology (438) 438
genetic aspects (437) 437
cell proliferation (428) 428
case-control studies (426) 426
health aspects (426) 426
ovarian cancer (423) 423
proteins (419) 419
endometrial neoplasms - diagnosis (412) 412
receptors, estrogen - metabolism (388) 388
mutation (387) 387
breast cancer (382) 382
abridged index medicus (380) 380
neoplasm invasiveness (372) 372
biochemistry & molecular biology (369) 369
signal transduction (352) 352
reverse transcriptase polymerase chain reaction (348) 348
endometrial hyperplasia - metabolism (345) 345
estrogen (338) 338
care and treatment (333) 333
ovarian neoplasms - metabolism (330) 330
receptors, progesterone - metabolism (326) 326
development and progression (324) 324
rna, messenger - metabolism (323) 323
male (322) 322
rna, messenger - genetics (322) 322
research article (320) 320
blotting, western (318) 318
obstetrics and gynecology (317) 317
metastasis (316) 316
carcinoma (314) 314
cell proliferation - drug effects (305) 305
hematology, oncology and palliative medicine (295) 295
endometrial neoplasms - mortality (282) 282
ovarian neoplasms - pathology (281) 281
retrospective studies (276) 276
endometrial hyperplasia - pathology (269) 269
apoptosis - drug effects (264) 264
endometrial neoplasms - epidemiology (264) 264
polymerase chain reaction (259) 259
immunoenzyme techniques (254) 254
medicine (249) 249
endometrial neoplasms - etiology (247) 247
cell cycle (245) 245
endometrial neoplasms - surgery (245) 245
kinases (243) 243
medicine, research & experimental (241) 241
research & experimental medicine (241) 241
genes (236) 236
biomarkers, tumor - analysis (232) 232
uterine neoplasms - metabolism (228) 228
physiological aspects (226) 226
endometrial neoplasms (225) 225
survival rate (225) 225
endometrial neoplasms - blood (223) 223
medical prognosis (221) 221
mice, nude (219) 219
neoplasm grading (219) 219
adenocarcinoma - genetics (217) 217
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6122) 6122
Chinese (182) 182
Russian (75) 75
Japanese (47) 47
Polish (32) 32
German (9) 9
Bulgarian (8) 8
French (8) 8
Spanish (8) 8
Czech (6) 6
Italian (6) 6
Portuguese (5) 5
Norwegian (4) 4
Hungarian (3) 3
Romanian (3) 3
Danish (2) 2
Croatian (1) 1
Icelandic (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current drug targets, ISSN 1389-4501, 11/2015, Volume 16, Issue 12, pp. 1381 - 1403
MicroRNAs (miRNAs) are small single stranded non coding RNA molecules (similar to 22 nucleotides) which impede protein production by directly interacting with... 
Epithelial to mesenchymal transition | Biomarker | Tumor microenvironment | Tumor suppressor | MicroRNAs | MiR-200c | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | MicroRNAs - therapeutic use | Neoplasms - metabolism | Lung Neoplasms - drug therapy | Prostatic Neoplasms - metabolism | Pancreatic Neoplasms - metabolism | Pancreatic Neoplasms - diagnosis | Humans | Lung Neoplasms - metabolism | Endometrial Neoplasms - metabolism | Stomach Neoplasms - metabolism | Male | MicroRNAs - metabolism | Antineoplastic Agents - therapeutic use | Neoplasms - diagnosis | Prostatic Neoplasms - diagnosis | Colorectal Neoplasms - diagnosis | Breast Neoplasms - metabolism | Pancreatic Neoplasms - drug therapy | Biomarkers, Tumor - therapeutic use | Colorectal Neoplasms - drug therapy | Biomarkers, Tumor - metabolism | Female | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Colorectal Neoplasms - metabolism | Prostatic Neoplasms - drug therapy | Stomach Neoplasms - diagnosis | Ovarian Neoplasms - diagnosis | Biomarkers, Tumor - physiology | Stomach Neoplasms - drug therapy | Endometrial Neoplasms - diagnosis | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Animals | Endometrial Neoplasms - drug therapy | Breast Neoplasms - diagnosis | MicroRNAs - physiology | Lung Neoplasms - diagnosis
Journal Article
Cancer chemotherapy and pharmacology, ISSN 1432-0843, 07/2019, Volume 84, Issue 3, pp. 487 - 499
Enzymes of the cytochrome P450 (CYP) subfamily 3A and 2C play a major role in the metabolism of taxane anticancer agents... 
Intratumoral | Ritonavir | Paclitaxel | Docetaxel | CYP | Review | Journal Article | Medicine & Public Health | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Taxoids - pharmacology | Humans | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Lung Neoplasms - pathology | Male | Breast Neoplasms - enzymology | Female | Antineoplastic Agents - pharmacology | Cytochrome P-450 CYP2C8 - metabolism | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Endometrial Neoplasms - enzymology | Lung Neoplasms - enzymology | Neoplasms - enzymology | Breast Neoplasms - drug therapy | Ovarian Neoplasms - enzymology | Neoplasms - drug therapy | Breast Neoplasms - pathology | Cytochrome P-450 CYP3A - metabolism | Prostatic Neoplasms - enzymology | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Neoplasms - pathology | Antimitotic agents | Protease inhibitors | Proteases | Pharmacy | Cytochrome P-450 | Physiological aspects | Drugstores | Antineoplastic agents | Ovarian cancer | Cytochrome | Enzymes | Cytochrome P450 | Proteinase inhibitors | Taxane | Metabolism | Anticancer properties | Antitumor agents | Lungs | Drug metabolism | Breast | Solid tumors | Taxanes | Prostate | Endometrium | Tumors | Cytochromes P450 | Index Medicus
Journal Article
Anticancer Research, ISSN 0250-7005, 08/2009, Volume 29, Issue 8, pp. 2875 - 2884
Background: To identify immunosuppressive elements present in ovarian cancer associated ascites. Patients and Methods: Ascites and plasma were obtained from... 
Cell mediated immunity | Cytokines | Ascites | Chemokines | Ovarian cancer | CD8-Positive T-Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Cystadenocarcinoma, Serous - metabolism | Endometrial Neoplasms - metabolism | Ovarian Neoplasms - pathology | CD4-Positive T-Lymphocytes - pathology | Adenocarcinoma, Clear Cell - immunology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Antigen-Presenting Cells - pathology | Endometrial Neoplasms - immunology | Flow Cytometry | Fallopian Tube Neoplasms - immunology | Aged, 80 and over | Ascites - immunology | CD8-Positive T-Lymphocytes - metabolism | Adult | Female | Ovarian Neoplasms - metabolism | Cystadenocarcinoma, Serous - immunology | Peritoneal Neoplasms - immunology | Peritoneal Neoplasms - pathology | Cystadenocarcinoma, Serous - secondary | Antigen-Presenting Cells - metabolism | Cytokines - metabolism | Adenocarcinoma, Clear Cell - metabolism | CD4-Positive T-Lymphocytes - metabolism | Fallopian Tube Neoplasms - pathology | Survival Rate | Chromium - metabolism | Antigen-Presenting Cells - immunology | Endometrial Neoplasms - secondary | Adenocarcinoma, Clear Cell - secondary | Ascites - metabolism | Peritoneal Neoplasms - metabolism | Aged | Fallopian Tube Neoplasms - metabolism | CD8-Positive T-Lymphocytes - immunology | Ascites - pathology | Ovarian Neoplasms - immunology | Index Medicus
Journal Article
2008, 1. Aufl., Advances in experimental medicine and biology, ISBN 0387690786, Volume 617, xlvi, 658
Information gathered from cell-free systems, cell cultures, animal models, and human studies, together will (1) provide important insights to our understanding... 
Carcinogenicity | Hormones | Congresses
Book
Pathology oncology research, ISSN 1219-4956, 4/2015, Volume 21, Issue 2, pp. 487 - 494
Serous adenocarcinoma of the cervix (SACC) is a very rare tumor. Our study aimed to characterize the immune profile and human papillomavirus (HPV) status of... 
Pathology | Serous adenocarcinoma | Human papillomavirus | Biomedicine | Immunology | Cancer Research | Oncology | Immunohistochemical features | Uterine cervix | Biomedicine general | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Neoplasms, Cystic, Mucinous, and Serous - metabolism | Humans | Uterine Cervical Neoplasms - epidemiology | Uterine Neoplasms - epidemiology | Endometrial Neoplasms - metabolism | Neoplasms, Cystic, Mucinous, and Serous - epidemiology | Neoplasm Proteins - metabolism | Cyclin-Dependent Kinase Inhibitor p16 | Adenocarcinoma - metabolism | Neoplasms, Cystic, Mucinous, and Serous - virology | Ovarian Neoplasms - virology | Uterine Cervical Neoplasms - metabolism | Female | Membrane Proteins - metabolism | Ovarian Neoplasms - metabolism | Retrospective Studies | CA-125 Antigen - metabolism | Uterine Neoplasms - metabolism | Comorbidity | Papillomavirus Infections - epidemiology | Tumor Suppressor Protein p53 - metabolism | Endometrial Neoplasms - virology | Immunophenotyping | Endometrial Neoplasms - epidemiology | Uterine Neoplasms - virology | Adenocarcinoma - virology | Ovarian Neoplasms - epidemiology | Papillomavirus Infections - metabolism | Uterine Cervical Neoplasms - virology | Papillomaviridae | Adenocarcinoma - epidemiology | Papillomaviruses | Adenocarcinoma | Medical colleges | Analysis | Resveratrol | Tumor proteins | Papillomavirus infections | Ovarian cancer | Index Medicus
Journal Article
Gynecologic oncology, ISSN 0090-8258, 11/2018, Volume 151, Issue 2, pp. 337 - 344
Paclitaxel, a microtubule inhibitor, is subject to tumor resistance while treating high-grade serous ovarian and uterine cancer. This study aims to directly... 
Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Paclitaxel - pharmacology | Apoptosis - drug effects | Tubulin Modulators - pharmacology | Humans | Receptor Protein-Tyrosine Kinases - biosynthesis | Cystadenocarcinoma, Serous - metabolism | Endometrial Neoplasms - metabolism | Ovarian Neoplasms - pathology | Neoplasms, Glandular and Epithelial - metabolism | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | Proto-Oncogene Proteins - biosynthesis | Cystadenocarcinoma, Serous - drug therapy | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Endometrial Neoplasms - genetics | Female | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Neoplasms, Glandular and Epithelial - pathology | Cell Growth Processes - drug effects | Proto-Oncogene Proteins - genetics | Mice, SCID | Xenograft Model Antitumor Assays | Animals | RNA, Neoplasm - biosynthesis | Receptor Protein-Tyrosine Kinases - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Cell Line, Tumor | RNA, Neoplasm - genetics | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Mice, Inbred NOD | Mice | Cell Cycle - drug effects | Colchicine | RNA | Uterine cancer | Tubulins | Growth | Analysis | Index Medicus
Journal Article
Endocrine-related cancer, ISSN 1351-0088, 10/2015, Volume 22, Issue 5, pp. 703 - 711
Aside from tumor cells, ovarian cancer-related ascites contains the immune components. The aim of this study was to evaluate whether a combination of clinical... 
Ovarian carcinoma | Ascites | Interleukin 17 | Risk-scoring system | Interleukin 21 | Tumor immunology | Oncology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Prognosis | Prospective Studies | Follow-Up Studies | Adenocarcinoma, Mucinous - pathology | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Cystadenocarcinoma, Serous - metabolism | Endometrial Neoplasms - metabolism | Ovarian Neoplasms - pathology | Ovarian Neoplasms - mortality | Cystadenocarcinoma, Serous - pathology | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Interleukins - metabolism | Neoplasm Recurrence, Local - pathology | Neoplasm Grading | Adenocarcinoma, Mucinous - surgery | Biomarkers, Tumor - metabolism | Female | Ovarian Neoplasms - metabolism | Adenocarcinoma, Clear Cell - surgery | Enzyme-Linked Immunosorbent Assay | Neoplasm Recurrence, Local - metabolism | Adenocarcinoma, Clear Cell - metabolism | Survival Rate | Cystadenocarcinoma, Serous - surgery | Adenocarcinoma, Mucinous - mortality | Interleukin-17 - metabolism | Adenocarcinoma, Mucinous - metabolism | Endometrial Neoplasms - surgery | Cystadenocarcinoma, Serous - mortality | Endometrial Neoplasms - pathology | ROC Curve | Adenocarcinoma, Clear Cell - pathology | Neoplasm Staging | Ovarian Neoplasms - surgery | Index Medicus
Journal Article